[Brachial-Basilic Arteriovenous Fistula Versus Arteriovenous Graft in Vascular Access for Maintenance Hemodialysis Patients].

OBJECTIVE:To compared the outcomes of autogenous brachial-basilic arteriovenous fistula (BBAVF) and AV graft (AVG) in patients undergoing long-term hemodialysis.METHODS:Approved by Zhong Da hospital ethics committee, we analyzed 61 complex patients, 30 randomized to receive AVG and 31 received BBAVF. We compared patency rates of BBAVF and AVG in 3 months, 1 year, 2 years, 3 years, and complication rates.RESULTS:Patency rates of BBAVF in 3 months, 1 year, 2 years, 3 years were 100%, 96.8%, 90.3%, 87.1%, 3 years accumulative total infection rate was 3.2%, thrombosis rate was 3.2%. Patency rates of AVG in 3 months, 1 year, 2 years, 3 years were 96.7%, 50.0%, 36.7%, 33.3%, 3 years accumulative total infection rate was 26.7%, thrombosis rate was 33.3%. Patency rates of BBAVF in 1 year, 2 years, 3 years were higher than patency rates of AVG. The complication rates of infection and thrombosis were significantly lower for BBAVF than for AVG (P < 0.05, respectively).CONCLUSIONS:BBAVF has the advantage of a higher patency rate, a lower complication rates of infection and thrombosis, should be served as a favourable choice in building the vascular access in maintenance hemodialysis patients.